Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil in Severe Pulmonary Hypertension Due to COPD
NCT05844462Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2024
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tadalafil in pulmonary hypertension (PH), sponsored by Assistance publique - Hôpitaux de Paris. Started Feb 2024; status: recruiting.
02
Drugs
tadalafil
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT05844462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05844462.